We are excited to share papers resulting from our groundbreaking & innovative courses covering: Aging: Science and Technology for Longevity, Healthcare Venture Capital, Longevity Venture Capitol and How We Age.

Gene 229 Course Aging

GENE 229:
How We Age

We all age, but how do we age? There are 79 organs in the human body and each of them age differently.

Some parts of the human body visibly age like hair and skin, others are less visible like our kidneys, liver and heart. What is the trajectory of aging for each of these organs and how can the aging of these organs be measured quantitatively?

Learn More >

GENE 226:
Longevity Venture Capital

Longevity covers therapeutics, robotics, and fintech. Yet as an emerging industry, how do these get financed?

How should venture firms evaluate longevity companies and how should founders attract investors and employees?


Read Papers from this course >

GENE 225:
Healthcare Venture Capital

How are healthcare startups financed? Venture funds invest in risky companies but how do they themselves get funded, and how do they evaluate companies?

Read Papers from this course >

GENE 223:
Aging – Science and Technology for Longevity


We will look at the biology of aging, transitioning from the molecular level through to the cellular and systems level. What are age-related diseases, can lifespan be extended and are centenarians different?

Read Papers from this course >






Empatica E4 Wristband

Infectious Disease and COVID-19
 Wearables Study

Can wearable devices help detect Infectious Disease or COVID-19 before symptoms emerge? 
Learn More >

Pac-12 Stanford Wearables Research Study

Crohn’s Exposome
Enrollment Now Open

This study investigates the role of human exposome in Crohn’s disease using wearable sensors and multiomics profiling.

Share This